Clinic
Valley Children's Hospital
Valley Children's Hospital was paid $14.28M by Medicaid between Jan 2018 and Dec 2024, across 75 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 96% of everything it billed.
33Billing provider infoVALLEY CHILDREN'S HOSPITAL
MADERA, CA 93636
MADERA, CA 93636
33aNPI1063573962assigned 12/13/2006
33bProvider typeRural Health Clinic/Center
28Total paid$14.28M
24GClaims175,135
24DCodes billed75
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in California
Rank by total paid#40 of 215
Median peer was paid$3.62M
This provider vs. median3.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,824 | $2.57M | |
| 2019 | 23,095 | $2.59M | |
| 2020 | 18,084 | $1.70M | |
| 2021 | 30,666 | $2.06M | |
| 2022 | 26,499 | $1.40M | |
| 2023 | 27,851 | $1.89M | |
| 2024incomplete | 26,116 | $2.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 96% | 64,540 | 61,225 | $13.67M |
| 99199 | Unlisted special service, procedure or report | 1.4% | 3,379 | 3,229 | $204K |
| 0521 | 1.1% | 2,543 | 2,308 | $150K | |
| 0760 | <1% | 23,702 | 22,188 | $115K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 8,012 | 7,590 | $26K |
| 0761 | <1% | 9,136 | 8,105 | $23K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 3,322 | 3,261 | $18K |
| Q3014 | Telehealth originating site facility fee | <1% | 6,457 | 6,117 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 8,508 | 8,250 | $10K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 8,522 | 8,196 | $5K |
| 0360 | <1% | 817 | 809 | $5K | |
| 99417 | Prolong home eval add 15m | <1% | 320 | 318 | $4K |
63 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,660 | $2K |
| 90686 | <1% | 5,622 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,120 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 41 | $2K |
| 0124A | <1% | 37 | $2K | |
| 97803 | <1% | 1,280 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 493 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 172 | $2K |
| 90651 | <1% | 1,279 | $1K | |
| J3490 | Unclassified drugs | <1% | 538 | $1K |
| 0001A | <1% | 29 | $1K | |
| 90734 | <1% | 648 | $1K | |
| 92551 | <1% | 3,421 | $1K | |
| 90620 | <1% | 792 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 271 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,402 | $712.80 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 984 | $617.98 |
| 80053 | Comprehensive metabolic panel | <1% | 689 | $590.98 |
| 96127 | <1% | 629 | $503.15 | |
| 90670 | <1% | 1,299 | $409.31 | |
| 99188 | <1% | 1,138 | $399.53 | |
| 90647 | <1% | 1,314 | $383.46 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 341 | $381.12 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 307 | $360.80 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 592 | $346.76 |
| 90715 | <1% | 488 | $269.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 60 | $267.54 |
| 94760 | <1% | 69 | $258.71 | |
| 69210 | <1% | 415 | $258.59 | |
| 90723 | <1% | 738 | $256.66 | |
| 90633 | <1% | 926 | $251.46 | |
| 83655 | <1% | 629 | $246.99 | |
| 85018 | <1% | 1,880 | $191.96 | |
| 90680 | <1% | 434 | $152.10 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 32 | $85.52 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 85 | $77.17 |
| 84439 | <1% | 104 | $71.96 | |
| 87430 | <1% | 66 | $61.08 | |
| 90710 | <1% | 217 | $53.25 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 185 | $52.50 |
| 81003 | <1% | 186 | $51.29 | |
| 99177 | <1% | 532 | $46.95 | |
| 90707 | <1% | 155 | $40.00 | |
| 90656 | <1% | 415 | $29.84 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 44 | $29.48 |
| 90716 | <1% | 67 | $28.30 | |
| 90696 | <1% | 230 | $24.59 | |
| 87081 | <1% | 65 | $19.62 | |
| 80061 | Lipid panel | <1% | 51 | $19.13 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 58 | $13.94 |
| 0270 | <1% | 96 | $12.53 | |
| 81001 | <1% | 33 | $6.83 | |
| G9920 | Screening performed and negative | 0% | 112 | $0.00 |
| 90700 | 0% | 24 | $0.00 | |
| 90685 | 0% | 20 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 30 | $0.00 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 12 | $0.00 |
| 90677 | 0% | 133 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 48 | $0.00 |
| 86580 | 0% | 67 | $0.00 | |
| 87088 | 0% | 13 | $0.00 | |
| 90688 | 0% | 32 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMYCROFT, TINA (SENIOR VP & CFO)
| Provider | Location | Paid |
|---|---|---|
| Valley Children's Hospital | Madera, CA | $107.11M |
| Valley Children's Hospital | Madera, CA | $22.84M |
| Valley Children's Hospital | Fresno, CA | $20.85M |
| ST Jude Hospital Yorba Linda | Santa Rosa, CA | $10.59M |
| Valley Children's Hospital | Madera, CA | $262K |
| Valley Children's Hospital | Fresno, CA | $53K |
| King County Public Hospital District No. 2 | Kirkland, WA | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.